Sorbitol Is a Severity Biomarker for <scp>PMM2‐CDG</scp> with Therapeutic ImplicationsAnna N. Ligezka, Éva Morava, William Brucker et al.|Annals of Neurology|2021Cited by 57
<i>ALG13</i> X‐linked intellectual disability: New variants, glycosylation analysis, and expanded phenotypesHind Alsharhan, Andrew K. Sobering, Miao He et al.|Journal of Inherited Metabolic Disease|2021Cited by 29
Spontaneous improvement of carbohydrate-deficient transferrin in PMM2-CDG without mannose observed in CDG natural history studyPeter Witters, Éva Morava, Andrew C. Edmondson et al.|Orphanet Journal of Rare Diseases|2021Cited by 21
Additional file 1 of Spontaneous improvement of carbohydrate-deficient transferrin in PMM2-CDG without mannose observed in CDG natural history studyPeter Witters, Éva Morava, Andrew C. Edmondson et al.|Figshare|2021Cited by 0